Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: Impact on adult height, body mass index, bone mineral content, and reproductive function

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 190-195

  Pasquino, Anna Maria ^a   Pucarelli, Ida ^a   Accardo, Fabiana ^a   Demiraj, Vitan ^a   Segni, Maria ^a   Di Nardo, Raffaella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN;

ARTICLE; BODY MASS; BONE MINERAL; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEIGHT; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REPRODUCTION;

EID: 38149138709     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1216     Document Type: Article

References (39)

1. Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB 1981 Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370-372
2. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB 1991 Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab 73:1235-1240
3. Kletter GB, Kelch RP 1994 Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79:331-334
4. Paul D, Conte FA, Grumbach MM Kaplan SL 1995 Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 80:546-551
5. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S 1996 Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 75:292-297
6. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F 1999 Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 141:140-144
7. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL 1999 Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 84:1973-1978
8. Heger S, Partsch C-J, Sippell WG 1999 Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 84:4583-4590
9. Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borrelli P, Osio D, Mengarda F, De Luca F, Tatò L 2000 End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 13(Suppl 1):773-780
10. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJJ, Drop SLS 2000 Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 13:765-772
11. Klein KO, Barnes KM, Jones JV, Feuillan P, Cutler GB 2001 Increased final height in precocious puberty after long-term treatment with LHRH agonists: the national institutes of health experiences. J Clin Endocrinol Metab 86:4711-4716
12. Adan L, Chemaitilly W, Trivin C, Brauner R 2002 Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment. Clin Endocrinol (Oxf) 56:297-302
13. Paterson WF, McNeill E, Young D, Donaldson MDC 2004 Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol (Oxf) 61:626-634
14. Tanaka T, Niimi H, Matsuo N, Fujieda K, Tachibana K, Ohyama K, Satoh M, Kugu K 2005 Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on central precocious puberty. J Clin Endocrinol Metab 90:1371-1376
15. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
16. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
17. Bayley N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: revised for use with the Greulich and Pyle hand standards. J Pediatr 40:423-441
18. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z 1997 Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. Horm Res 47:54-61
19. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 allowing for height of parents. Arch Dis Child 45:755-762
20. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A 2006 Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581-593
21. Kroger H, Vainio P, Nieminen J, Kotaniemi A 1995 Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 17:157-159
22. Cisternino M, Arrigo T, Pasquino AM, Tinelli C, Antoniazzi F, Beduschi L, Bindi G, Borrelli P, De Sanctis V, Farello V, Galluzzi F, Gargantini L, Lo Presti D, Sposito M, Tatò L 2000 Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab 13(Suppl 1):695-701
23. Castellino N, Bellone S, Rapa A, Vercellotti A, Binotti M, Petri A, Bona G 2005 Puberty onset in Northern Italy: a random sample of 3597 Italian children. J Endocrinol Invest 28:589-594
24. Palmert MR, Mansfield MJ, Crowley WF, Crigler JF, Crawford JD, Boepple PA 1999 Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 84:4480-4488
25. Traggiai C, Polo Perucchin P, Zerbini K, Gastaldi R, DeBiasio P, Lorini R 2005 Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height. Eur J Endocrinol 152:463-464
26. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Segni M, Rosano M, Messina MF, Lombardo F 2004 Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur J Endocrinol 150:533-537
27. Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G 1993 Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 152:717-720
28. Verrotti A, Chiarelli F, Montanaro AF, Morgese G 1995 Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog. Gynecol Endocrinol 9:277-281
29. Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, Adami S, Tatò L 1995 Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment. Eur J Endocrinol 133:412-417
30. Boot AM, de Muinck-Keizer-Schrama SMPF, Pols HAP, Krenning EP, Drop SLS 1998 Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 83:370-373
31. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G 1998 Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 157:363-367
32. Antoniazzi F, Bertoldo F, Lauriola S, Sirpresi S, Gasperi E, Zamboni G, Tatò L 1999 Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab 84:1992-1996
33. Van der Sluis IM, Boot AM, Krenning EP, Drop SLS, De Muinck Keizer-Schrama SMPF 2002 Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 87:506-512
34. Tonini G, Lazzerini M 2000 Side effects of GnRH analogue treatment in childhood. J Pediatr Endocrinol Metab 13(Suppl 1):795-803
35. Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler Jr GB 1988 Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J Clin Endocrinol Metab 67:368-372
36. Jay N, Mansfield MJ, Blizzard RM, Crowley WF, Schoenfeld D, Rhubin L, Boepple PA 1992 Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 75:890-894
37. Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB 1999 Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 84:44-49
38. Arrigo T, De Luca F, Antoniazzi F, Galluzzi F, Iughetti L, Pasquino AM, Salerno MC, Marseglia L, Crisafulli G 2007 Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment. Eur J Pediatr 166:73-74
39. Carel JC, Lahlou N, Roger M, Chaussain JC 2004 Precocious puberty and statural growth. Hum Reprod Update 10:135-147